Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Childhood absence epilepsy (CAE) is a genetically complex disorder with well‐documented heritability. Recent linkage and association studies have implicated CACNG3 in disease susceptibility. Notably, a study evaluating 65 nuclear families demonstrated a significant HLOD score of 3.54, strongly supporting the involvement of CACNG3 in CAE (PMID:17264864).
In these analyses, transmission disequilibrium testing performed in 217 CAE trios further corroborated the association between CACNG3 and the clinical phenotype. The robust statistical signals obtained from such multi‐family studies underscore the gene’s contribution to disease risk (PMID:17264864).
Despite these positive genetic findings, re‐sequencing of CACNG3 coding exons in 59 patients did not identify any putative causal coding variants. Instead, a focused re‐sequencing of a 35 kb region around the 5′UTR and intron 1 revealed 72 non‐coding variants, four of which are predicted to affect exonic splicing. While these non‐coding changes lack the straightforward interpretability of coding mutations, they suggest potential regulatory disruptions contributing to CAE pathogenesis.
This genetic evidence is further complemented by functional assessment studies. Investigations into auxiliary calcium channel subunits, including CACNG3, have demonstrated key roles in synaptic function and neuronal excitability. Although direct functional assays for CACNG3 in CAE are limited, these studies provide supportive, albeit modest, experimental evidence for its possible pathogenic mechanism (PMID:36598609).
The absence of a clearly defined coding change meeting HGVS standards does not detract from the strong linkage and transmission disequilibrium signals, nor from the supportive inferred regulatory implications. Together, these findings integrate to form a coherent narrative that supports CACNG3 as a strong candidate gene for CAE, despite some limitations in the direct genetic variant evidence.
Key take‑home: CACNG3, supported by robust linkage and association data and consistent with the functional role of auxiliary calcium channel subunits in neuronal excitability, represents a promising target for genetic testing, diagnostic decision‑making, and future therapeutic research in childhood absence epilepsy.
Gene–Disease AssociationStrongLinkage analysis in 65 nuclear families revealing a significant HLOD score (3.54) and transmission disequilibrium in 217 CAE trios provides compelling evidence of association (PMID:17264864). Genetic EvidenceModerateAlthough re‑sequencing of coding exons in 59 patients revealed no causal variants, non‑coding regulatory variants in a 35 kb region support a moderate level of genetic evidence (PMID:17264864). Functional EvidenceLimitedFunctional evidence is inferred from studies on auxiliary calcium channel subunits, with direct assays for CACNG3 in CAE remaining sparse (PMID:36598609). |